These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38027038)

  • 1. Hematological and Biochemical Laboratory Parameters in COVID-19 Patients: A Retrospective Modeling Study of Severity and Mortality Predictors.
    Alizad G; Ayatollahi AA; Shariati Samani A; Samadizadeh S; Aghcheli B; Rajabi A; Nakstad B; Tahamtan A
    Biomed Res Int; 2023; 2023():7753631. PubMed ID: 38027038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The İmportance of hematological parameters in the prognosis of patients with severe COVID-19, A single-center retrospective study.
    Gozukucuk R; Kılıc HH; Uyanik BS; Cakiroglu B
    Niger J Clin Pract; 2023 Sep; 26(9):1297-1302. PubMed ID: 37794542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients.
    Ok F; Erdogan O; Durmus E; Carkci S; Canik A
    J Med Virol; 2021 Feb; 93(2):786-793. PubMed ID: 32662893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do routine laboratory tests change in coronavirus disease 2019?
    Mertoglu C; Huyut MT; Arslan Y; Ceylan Y; Coban TA
    Scand J Clin Lab Invest; 2021 Feb; 81(1):24-33. PubMed ID: 33342313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.
    Keykavousi K; Nourbakhsh F; Abdollahpour N; Fazeli F; Sedaghat A; Soheili V; Sahebkar A
    Int J Anal Chem; 2022; 2022():9006487. PubMed ID: 36267156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hematological parameters alterations in different waves of COVID-19 pandemic: A cross-sectional study.
    Charostad J; Rezaei Zadeh Rukerd M; Shahrokhi A; Aghda FA; Ghelmani Y; Pourzand P; Pourshaikhali S; Dabiri S; Dehghani A; Astani A; Nakhaie M; Kakavand E
    PLoS One; 2023; 18(8):e0290242. PubMed ID: 37624800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M
    PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.
    Dwivedi T; Raj A; Das N; Gupta R; Gupta N; Tiwari P; Sahoo B; Sagiraju HKR; Sirohiya P; Ratre B; Elavarasi A; Mohan A; Bhatnagar S
    Cureus; 2023 Jun; 15(6):e40273. PubMed ID: 37448393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Determinants of Mortality in Patients With COVID-19: A Retrospective Analytical Cross-Sectional Study in a Tertiary Care Center in South India.
    Kurien SS; David RS; Chellappan AK; Varma RP; Pillai PR; Yadev I
    Cureus; 2022 Mar; 14(3):e23103. PubMed ID: 35464560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Death in Comorbidity Subgroups of Hospitalized COVID-19 Patients Inferred by Routine Laboratory Markers of Systemic Inflammation on Admission: A Retrospective Study.
    Cocoş R; Mahler B; Turcu-Stiolica A; Stoichiță A; Ghinet A; Shelby ES; Bohîlțea LC
    Viruses; 2022 May; 14(6):. PubMed ID: 35746672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 15. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients.
    Kumar Y; Kumari A; Kumar T; Jha K; Zabihullah M
    Cureus; 2023 Sep; 15(9):e45276. PubMed ID: 37846240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study.
    Damiati LA; Bahlas S; Aljohaney A; Bawazir Y; Mustafa M; Denetiu I; Pushparaj PN
    J Infect Public Health; 2022 Feb; 15(2):214-221. PubMed ID: 35007842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected Hematological Biomarkers to Predict Acute Mortality in Emergency Department Patients. Recent Polish Hospital Statistics.
    Brzeźniakiewicz-Janus K; Lancé MD; Tukiendorf A; Janus T; Franków M; Rupa-Matysek J; Walkowiak Z; Gil L
    Dis Markers; 2020; 2020():8874361. PubMed ID: 32724484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the clinical characteristics of severe tsutsugamushi disease in Yunnan Province from 2017 to 2018].
    Wang Y; Li M; Xu W; Wang Y; Qian R; Zhao W; Dai D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):1018-1023. PubMed ID: 31537231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.